Please login to the form below

Not currently logged in
Email:
Password:

HeartCel

This page shows the latest HeartCel news and features for those working in and with pharma, biotech and healthcare.

Celixir cleared to start trial of stem cell therapy for heart failure

Celixir cleared to start trial of stem cell therapy for heart failure

Previous trial demonstrated patients achieving 100% MACE free survival. UK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel - its stem cell-based therapy ... The initial Heartcel trial results are very exciting, showing

Latest news

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    Additional undisclosed payments will also be forthcoming if HeartCel passes other development and regulatory milestones, as well as royalties on any future sales. ... HeartCel has been clinically tested with heart failure patients who undergo bypass

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics